Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Aging|July 5, 2012
The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetesMeital Halperin-Sheinfeld, Asaf Gertler, Eitan Okun, et al.Plos One|December 5, 2014
AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathwayItay Israel Shemesh, Benaya Rozen-Zvi, Yona Kalechman, et al.International Immunopharmacology|June 12, 2012
The immune-modulator AS101 reduces anti-HLA antibodies in sera of sensitized patients: a structural approachMoshe Israeli, Benjamin Sredni, Eitan Mor, et al.Chembiochem : a European Journal of Chemical Biology|March 19, 2016
The Anticancer Activity of Organotelluranes: Potential Role in Integrin InactivationAlon Silberman, Yona Kalechman, Shira Hirsch, et al.ACS Applied Bio Materials|January 15, 2022
AS101-Loaded PLGA-PEG Nanoparticles for Autoimmune Regulation and ChemosensitizationRahul Kumar Mishra, Vijay Bhooshan Kumar, Lea Monteran, et al.Frontiers in Immunology|March 23, 2017
The Small Tellurium Compound AS101 Ameliorates Rat Crescentic Glomerulonephritis: Association with Inhibition of Macrophage Caspase-1 Activity <i>via</i> Very Late Antigen-4 InactivationYafit Hachmo, Yona Kalechman, Itai Skornick, et al.Experimental Hematology|April 21, 2009
Induction therapy in a multiple myeloma mouse model using a combination of AS101 and melphalan, and the activity of AS101 in a tumor microenvironment modelMichal Hayun, Hagar Saida, Michael Albeck, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating interventionYona Kalechman, Uzi Gafter, Rivka Gal, et al.Annals of the New York Academy of Sciences|April 4, 2007
Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase FerRami Hayun, Sali Shpungin, Hana Malovani, et al.Leukemia & Lymphoma|April 18, 2009
Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cellsRami Hayun, Eitan Okun, Alain Berrebi, et al.Pageof 6